Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Ayurvedic treatment can effectively manage PCOS and its symptoms.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

Some medications and supplements can affect male fertility, with some improving and others harming sperm quality.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Low testosterone and SHBG levels are linked to higher COVID-19 death rates.

The study concluded that hair loss in Indian women is not significantly linked to anemia or thyroid problems, but checking thyroid function could help those with ongoing hair loss.

Nanostructured lipid carriers are promising for improving drug delivery in medicine and food.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

No effective treatment for hair loss after childbirth was found, but it usually gets better on its own and some cosmetic methods might help.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

Higher DHT in male baldness may protect against prostate cancer.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Women with different PCOS types have similar fertility treatment results.

PCOS affects many women, causing various symptoms and health risks, and is managed through lifestyle changes, medication, and support groups.

High levels of prolactin in the blood can be linked to widespread hair loss.

Microneedles offer a painless, effective way to deliver drugs through the skin.

Most people in the surveyed area experience hair loss, but they are not aware of the role of diet, iron, hormones, genetics, and possibly water quality in causing it.